Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

502 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravitreal Delivery of rAAV2tYF-CB-hRS1 Vector for Gene Augmentation Therapy in Patients with X-Linked Retinoschisis: 1-Year Clinical Results.
Pennesi ME, Yang P, Birch DG, Weng CY, Moore AT, Iannaccone A, Comander JI, Jayasundera T, Chulay J; XLRS-001 Study Group. Pennesi ME, et al. Among authors: moore at. Ophthalmol Retina. 2022 Dec;6(12):1130-1144. doi: 10.1016/j.oret.2022.06.013. Epub 2022 Jun 30. Ophthalmol Retina. 2022. PMID: 35781068 Clinical Trial.
A phenotype-genotype correlation study of X-linked retinoschisis.
Vincent A, Robson AG, Neveu MM, Wright GA, Moore AT, Webster AR, Holder GE. Vincent A, et al. Among authors: moore at. Ophthalmology. 2013 Jul;120(7):1454-64. doi: 10.1016/j.ophtha.2012.12.008. Epub 2013 Feb 28. Ophthalmology. 2013. PMID: 23453514
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
Strauss RW, Ho A, Muñoz B, Cideciyan AV, Sahel JA, Sunness JS, Birch DG, Bernstein PS, Michaelides M, Traboulsi EI, Zrenner E, Sadda S, Ervin AM, West S, Scholl HP; Progression of Stargardt Disease Study Group. Strauss RW, et al. Ophthalmology. 2016 Apr;123(4):817-28. doi: 10.1016/j.ophtha.2015.12.009. Epub 2016 Jan 16. Ophthalmology. 2016. PMID: 26786511
Molecular and Clinical Findings in Patients With Knobloch Syndrome.
Hull S, Arno G, Ku CA, Ge Z, Waseem N, Chandra A, Webster AR, Robson AG, Michaelides M, Weleber RG, Davagnanam I, Chen R, Holder GE, Pennesi ME, Moore AT. Hull S, et al. Among authors: moore at. JAMA Ophthalmol. 2016 Jul 1;134(7):753-62. doi: 10.1001/jamaophthalmol.2016.1073. JAMA Ophthalmol. 2016. PMID: 27259167
Detailed Clinical Phenotype and Molecular Genetic Findings in CLN3-Associated Isolated Retinal Degeneration.
Ku CA, Hull S, Arno G, Vincent A, Carss K, Kayton R, Weeks D, Anderson GW, Geraets R, Parker C, Pearce DA, Michaelides M, MacLaren RE, Robson AG, Holder GE, Heon E, Raymond FL, Moore AT, Webster AR, Pennesi ME. Ku CA, et al. Among authors: moore at. JAMA Ophthalmol. 2017 Jul 1;135(7):749-760. doi: 10.1001/jamaophthalmol.2017.1401. JAMA Ophthalmol. 2017. PMID: 28542676 Free PMC article.
Bullous X linked retinoschisis: clinical features and prognosis.
Hinds AM, Fahim A, Moore AT, Wong SC, Michaelides M. Hinds AM, et al. Among authors: moore at. Br J Ophthalmol. 2018 May;102(5):622-624. doi: 10.1136/bjophthalmol-2017-310593. Epub 2017 Aug 28. Br J Ophthalmol. 2018. PMID: 28848025
XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa.
MacLaren RE, Duncan JL, Fischer MD, Lam BL, Meunier I, Pennesi ME, Sankila EK, Gow JA, Li J, Tsang SF; XOLARIS Study Group. MacLaren RE, et al. Ophthalmol Sci. 2024 Aug 13;5(1):100595. doi: 10.1016/j.xops.2024.100595. eCollection 2025 Jan-Feb. Ophthalmol Sci. 2024. PMID: 39493534 Free PMC article.
502 results